Outcomes of transfemoral TAVR using two new‐generation devices in patients with horizontal aorta
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.31094 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Clemens Eckel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, St. Johannes Hospital, Dortmund, Germany. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Heart Valve Prosthesis, Prosthesis Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Challenging anatomies and comorbidities have impact on success in transcatheter aortic valve replacement (TAVR). There is controversy whether the extent of the aortic angle (AA) has an impact on procedural outcomes. Matched comparative outcome data of new generation transcatheter heart valves (THVs) in horizontal aorta (HA) are scarce.
Methods
A total of 1582 patients with severe native aortic stenosis (AS) treated with the SAPIEN3 Ultra (Ultra; n = 526) or ACURATE Neo2 (Neo2; n = 1056) THVs from January 2017 to January 2023 were analyzed. Patients with non‐horizontal aortas (AA < 51.7°, n = 841) were excluded. The population was matched by 1‐to‐1 nearest‐neighbor matching (Ultra, n = 246; Neo2, n = 246). Clinical and procedural outcome were evaluated according to VARC‐3 recommendations.
Results
Technical success (93.1% vs. 94.7%, p = 0.572) was high after Ultra and Neo2. Device success (80.5% vs. 89.8%, p = 0.05) was inferior with Ultra. Neo2 reveals superior hemodynamic properties with lower rate of severe prosthesis patient mismatch (12.0% vs. 3.7%, p = 0.001) and elevated gradients (20 mmHg: 11.9% vs. 1.7%, p < 0.001). Ultra showed a lower rate of relevant paravalvular regurgitation (mild paravalvular regurgitation or Valve‐in‐Valve due to paravalvular regurgitation: 0.0% vs. 3.7%, p = 0.004). The rate of procedural bailout maneuvers (0.8% vs. 0.4%, p = 1.000) and thirty‐day all‐cause mortality (1.3% vs. 2.2%, p = 0.496) was similar.
Conclusion
Transfemoral TAVR in patients with severe aortic stenosis and HA, using the balloon expandable Sapien3 Ultra and self‐expanding ACURATE Neo2 prosthesis, is feasible and safe. Therefore, valve selection between these platforms should be made irrespective of the aortic angle by a team experienced with both valves based on their specific advantages. Large, randomized trials in this sub‐group of patients would be necessary to compare long term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, St. Johannes Hospital, Dortmund, Germany.
- Carl von Ossietzky Universität Oldenburg, School VI, School of Medicine and Health Sciences, Oldenburg, Germany.
- Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany.
- Department of Cardiac Surgery, Kerckhoff Heart Center, Bad Nauheim, Germany.
- Department of Cardiac Surgery, University of Kiel, Kiel, Germany.
- Department of Cardiac Surgery, St. Johannes Hospital, Dortmund, Germany.
ORCID-Profile: Clemens Eckel, Won-Keun Kim, Johannes Blumenstein
Zitieren
APA
Eckel, C., Kim, W. K., Wasif, B., Grothusen, C., Elsässer, A., Dohmen, G., Charitos, E. I., Sossalla, S., Möllmann, H., & Blumenstein, J. (2024). Outcomes of transfemoral TAVR using two new‐generation devices in patients with horizontal aorta. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31094
Vancouver
Eckel C, Kim WK, Wasif B, Grothusen C, Elsässer A, Dohmen G, et al. Outcomes of transfemoral TAVR using two new‐generation devices in patients with horizontal aorta. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31094
BibTeX
@article{Eckel2024,
author = {Eckel, Clemens and Kim, Won-Keun and Wasif, Botros and Grothusen, Christina and Elsässer, Albrecht and Dohmen, Guido and Charitos, Efstratios I and Sossalla, Samuel and Möllmann, Helge and Blumenstein, Johannes},
title = {Outcomes of transfemoral TAVR using two new‐generation devices in patients with horizontal aorta},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.31094}
}
EUVIMED